Sat, Dec 20, 2014, 6:33 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Forest Laboratories Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • frankposting frankposting Dec 31, 2012 1:07 PM Flag

    Bystolic Cliff Is Coming Sooner Than Namenda Cliff

    A sort of "pay ($9M to Glenmark) for delay generics." Seemingly, Glenmark will be settled.

    Still two more (Amerigen and Watson) to go.

    By Zacks Equity Research | Zacks – 4 hours ago..
    12/31

    Forest Labs (FRX) and Glenmark Pharmaceuticals S.A, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India, recently signed a collaboration agreement. The companies will work on the development of novel mPGES-1 inhibitors for the treatment of chronic inflammatory conditions, including pain.

    Potential candidates have already been identified by Glenmark. Glenmark is conducting pre-clinical studies with these candidates prior to the initiation of human studies.

    Glenmark will receive an upfront payment of $6 million from Forest Labs. Moreover, Forest Labs will pay $3 million to fund the next phase of work. Additional payments will be made by Forest Labs in fiscal 2014 to support the development program. Once phase I development is completed, Forest Labs has an exclusive option to acquire licensing rights to the program.

 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.